99 related articles for article (PubMed ID: 29374786)
1. Metal-free salan-type compound induces apoptosis and overcomes multidrug resistance in leukemic and lymphoma cells in vitro.
Dragoun M; Günther T; Frias C; Berkessel A; Prokop A
J Cancer Res Clin Oncol; 2018 Apr; 144(4):685-695. PubMed ID: 29374786
[TBL] [Abstract][Full Text] [Related]
2. [Fe(III)(salophene)Cl], a potent iron salophene complex overcomes multiple drug resistance in lymphoma and leukemia cells.
Lee SY; Hille A; Kitanovic I; Jesse P; Henze G; Wölfl S; Gust R; Prokop A
Leuk Res; 2011 Mar; 35(3):387-93. PubMed ID: 21131047
[TBL] [Abstract][Full Text] [Related]
3. (2,6-Dimethylphenyl)arsonic Acid Induces Apoptosis through the Mitochondrial Pathway, Downregulates XIAP, and Overcomes Multidrug Resistance to Cytostatic Drugs in Leukemia and Lymphoma Cells In Vitro.
Wilke N; Frias C; Berkessel A; Prokop A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731935
[TBL] [Abstract][Full Text] [Related]
4. A metal-free salalen ligand with anti-tumor and synergistic activity in resistant leukemia and solid tumor cells via mitochondrial pathway.
Hopff SM; Wang Q; Frias C; Ahrweiler M; Wilke N; Wilke N; Berkessel A; Prokop A
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2591-2607. PubMed ID: 34213662
[TBL] [Abstract][Full Text] [Related]
5. KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri.
Kater L; Kater B; Jakupec MA; Keppler BK; Prokop A
J Biol Inorg Chem; 2021 Dec; 26(8):897-907. PubMed ID: 34617137
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
Gupta A; Le A; Belinka BA; Kachlany SC
Leuk Res; 2011 Nov; 35(11):1498-505. PubMed ID: 21664691
[TBL] [Abstract][Full Text] [Related]
7. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
[TBL] [Abstract][Full Text] [Related]
8. The rare-earth yttrium complex [YR(mtbmp)(thf)] triggers apoptosis via the extrinsic pathway and overcomes multiple drug resistance in leukemic cells.
Lee SY; Peckermann I; Abinet E; Okuda J; Henze G; Prokop A
Med Oncol; 2012 Mar; 29(1):235-42. PubMed ID: 21191668
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines.
Zheng B; Zhou R; Gong Y; Yang X; Shan Q
Int J Lab Hematol; 2012 Jun; 34(3):237-47. PubMed ID: 22145750
[TBL] [Abstract][Full Text] [Related]
10. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
11. The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of Harakiri and downregulation of XIAP in vitro.
Wilke NL; Abodo LO; Frias C; Frias J; Baas J; Jakupec MA; Keppler BK; Prokop A
Biomed Pharmacother; 2022 Dec; 156():113974. PubMed ID: 36411649
[TBL] [Abstract][Full Text] [Related]
12. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
13. The role of the intrinsic FAS pathway in Titanocene Y apoptosis: The mechanism of overcoming multiple drug resistance in malignant leukemia cells.
Kater L; Claffey J; Hogan M; Jesse P; Kater B; Strauss S; Tacke M; Prokop A
Toxicol In Vitro; 2012 Feb; 26(1):119-24. PubMed ID: 21986259
[TBL] [Abstract][Full Text] [Related]
14. Combination of tipifarnib and rapamycin synergistically inhibits the growth of leukemia cells and overcomes resistance to tipifarnib via alteration of cellular signaling pathways.
Nagai T; Ohmine K; Fujiwara S; Uesawa M; Sakurai C; Ozawa K
Leuk Res; 2010 Aug; 34(8):1057-63. PubMed ID: 20071026
[TBL] [Abstract][Full Text] [Related]
15. Targeting biliverdin reductase overcomes multidrug resistance in leukemia HL60 cells.
Kim SS; Seong S; Lim SH; Kim SY
Anticancer Res; 2013 Nov; 33(11):4913-9. PubMed ID: 24222129
[TBL] [Abstract][Full Text] [Related]
16. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
[TBL] [Abstract][Full Text] [Related]
17. Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.
Chen B; Yin L; Cheng J; Ding J; Gao C; Sun Y; Zhao G; Wang J; Bao W; Xia G; Gao F; Wang X
Hematology; 2011 Jan; 16(1):24-30. PubMed ID: 21269564
[TBL] [Abstract][Full Text] [Related]
18. Iron containing anti-tumoral agents: unexpected apoptosis-inducing activity of a ferrocene amino acid derivative.
Kater B; Hunold A; Schmalz HG; Kater L; Bonitzki B; Jesse P; Prokop A
J Cancer Res Clin Oncol; 2011 Apr; 137(4):639-49. PubMed ID: 20544219
[TBL] [Abstract][Full Text] [Related]
19. Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptide.
Roboz J; Jiang J; Holland JF; Bekesi JG
Cancer Res; 1997 Nov; 57(21):4795-802. PubMed ID: 9354441
[TBL] [Abstract][Full Text] [Related]
20. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
